Harbin Medical University

This study looks at how well immunotherapy drug combinations work for people with liver cancer living in cold parts of China. Researchers will track 1,000 patients to see if these treatments help them live longer and slow cancer growth. The goal is to find the best treatment plan…

This study tests whether adding risedronate (a bone drug) to camrelizumab (an immunotherapy) and chemotherapy can help people with triple-negative breast cancer. The goal is to overcome treatment resistance and improve tumor shrinkage. About 30 women aged 18-70 are taking part.

This study tests whether taking vitamin K2 supplements for one year can improve muscle strength, muscle mass, and brain function in people who recently had an ischemic stroke. 190 participants will receive either vitamin K2 or a placebo pill daily. Researchers will measure handgr…